Top Markets
#1 BSquared Network BSquared Network +86.70%
#2 Derive Derive +34.14%
#3 Akedo Akedo +30.98%
#4 DogBull DogBull +30.84%
#5 Arweave Arweave +23.96%
#6 MetaDAO MetaDAO +22.00%
#7 Zama Zama +21.78%
#8 Tezos Tezos +17.94%
#9 Cortex Cortex +14.73%
#10 Kinetiq Kinetiq +14.65%
Coin of the day
BSquared Network BSquared Network
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Rankning i aktier #100
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations... Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Aktiekurs
$150.78
Senast synkroniserad: 2026-09-18
Marknadsvärde
$187.20B
Förändring (1 dag)
-0.08%
Förändring (1 år)
32.15%
Land
US
Handel Gilead Sciences, Inc. (GILD)

Kategori

Healthcare
Utdelningsavkastning för Gilead Sciences, Inc. (GILD)
Utdelningsavkastningen (TTM) för Gilead Sciences, Inc. (aktiesymbol: GILD) per 2024-12-31 är: 3.40%
Genomsnittlig utdelningsavkastning de senaste 5 åren: 3.43%
Historik för utdelningsavkastning för Gilead Sciences, Inc. (GILD) från 2000 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
År Utdelningsavkastning Ändra
2026 (TTM) 2.22% -13.62%
2025 2.57% -24.41%
2024 3.40% -9.81%
2023 3.77% 9.59%
2022 3.44% -12.91%
2021 3.95% -16.14%
2020 4.71% 20.77%
2019 3.90% 6.56%
2018 3.66% 25.34%
2017 2.92% 14.06%
2016 2.56% 101.57%
2015 1.27% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
2009 0.00% 0.00%
2008 0.00% 0.00%
2007 0.00% 0.00%
2006 0.00% 0.00%
2005 0.00% 0.00%
2004 0.00% 0.00%
2003 0.00% 0.00%
2002 0.00% 0.00%
2001 0.00% 0.00%
2000 0.00% 0.00%
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter
Företag Utdelningsavkastning Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
0.59%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
1.98%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
2.61%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
2.69%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
2.35%
US